Australia's Microba Life Sciences slips on fall in quarterly revenue
** Shares of Microba Life Sciences MAP.AX fall as much as 3.8% to A$0.076, their biggest intraday pct fall since October 10; stock last down 2.5% ** Health sciences co reports quarterly revenue of A$3.6 million ($2.34 million), down 1% vs pcp ** Stock is down 60.5% YTD, including the session's moves ($1 = 1.5389 Australian dollars) (Reporting by Anjali Singh in Bengaluru) ((anjali.singh2@thomsonreuters.com;))
Recent news on Microba Life Sciences
See all newsAustralia's Microba Life Sciences slumps to record low on discounted placement
Brief: Microba Life Sciences Secures A$5 Million Placement At A$0.05 Per Share
Brief: Microba Life Sciences Seeks Trading Halt
Brief: Microba Life Sciences Logs Qtrly Total Revenue A$3.36 Mln
Brief: Microba Life Sciences Posts HY Loss Attributable A$10.6 Million